Scribd
Upload
1K views

Cioms Form

This document is a report form for reporting suspect adverse drug reactions. It requests information about: [1] the patient and reaction details, including description of the reaction(s) and relevant test/lab data; [2] the suspect drug(s) involved including dose, route of administration, indication for use, therapy duration and dates; [3] any concomitant drugs and relevant medical history; and [4] manufacturer information including the report source, type, and dates. The form is used to collect essential information to evaluate potential adverse drug reactions.

Uploaded by

naura_farrel
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
1K views

Cioms Form

This document is a report form for reporting suspect adverse drug reactions. It requests information about: [1] the patient and reaction details, including description of the reaction(s) and relevant test/lab data; [2] the suspect drug(s) involved including dose, route of administration, indication for use, therapy duration and dates; [3] any concomitant drugs and relevant medical history; and [4] manufacturer information including the report source, type, and dates. The form is used to collect essential information to evaluate potential adverse drug reactions.

Uploaded by

naura_farrel
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
You are on page 1/ 2

CIOMS FORM

SUSPECT ADVERSE REACTION REPORT

I. REACTION INFORMATION
1. PATIENT INITIALS (first, last) 1a. COUNTRY 2. DATE OF BIRTH Day Month Year 2a. AGE Years 3. SEX 4-6 REACTION ONSET Day Month Year 8-12 CHECK ALL APPROPRIATE TO ADVERSE REACTION PATIENT DIED INVOLVED OR PROLONGED INPATIENT HOSPITALISATION INVOLVED PERSISTENT OR SIGNIFICANT DISABILITY OR INCAPACITY LIFE THREATENING CONGENITAL ANOMALY OTHER MEDICALLY IMPORTANT CONDITION

7 + 13 DESCRIBE REACTION(S) (including relevant tests/lab data)

II. SUSPECT DRUG(S) INFORMATION


14. SUSPECT DRUG(S) (include generic name) 20. DID REACTION ABATE AFTER STOPPING DRUG? YES NO NA 16. ROUTE(S) OF ADMINISTRATION 21. DID REACTION REAPPEAR AFTER REINTRODUCTION? YES NO NA 19. THERAPY DURATION

15. DAILY DOSE(S)

17. INDICATION(S) FOR USE 18. THERAPY DATES (from/to)

III. CONCOMITANT DRUG(S) AND HISTORY


22. CONCOMITANT DRUG(S) AND DATES OF ADMINISTRATION (exclude those used to treat reaction)

23. OTHER RELEVANT HISTORY (e.g. diagnoses, allergies, pregnancy with last menstrual period, etc.)

IV. MANUFACTURER INFORMATION

24a. NAME AND ADDRESS OF MANUFACTURER

26-26a. NAME AND ADRESS OF REPORTER (INCLUDE ZIP CODE)

ORIGINAL REPORT NO. 24c. DATE RECEIVED BY MANUFACTURER

24b. MFR CONTROL NO. 24d. REPORT SOURCE STUDY LITERATURE HEALTH PROFESSIONAL REGULATORY AUTHORITY OTHER 25a. REPORT TYPE INITIAL FOLLOW-UP

DATE OF THIS REPORT

You might also like